Acutaas Chemicals Current Share Price | Acutaas Chemicals Stock Screener
ACUTAAS
Pharmaceuticals
Acutaas Chemicals Current Stock Price Today
Live Share Price NSE
₹3440.30
▲
125.20 (3.78%)
Live Share Price BSE
₹3438.15
▲
122.55 (3.70%)
As of September 18, 2026, the live Acutaas Chemicals share price (NSE: ACUTAAS) is ₹3,440.30 on NSE and ₹3,438.15 on BSE, up 3.78% from the previous close, with shares trading between ₹3,302.50 and ₹3,462.00 in today's trading session, and a 52-week range of ₹1,318.90–₹3,694.80.
Browse ACUTAAS income statement to support your investment research.
Use the Acutaas Chemicals stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Acutaas Chemicals Market Cap
₹26,740.75 Cr.
ACUTAAS P/E Ratio (TTM)
71.39
Acutaas Chemicals P/B Ratio
17.09
EPS (TTM)
₹43.51
Dividend Yield
0.07%
Debt to Equity
0.02
ACUTAAS 52 Week High
₹3694.80
Acutaas Chemicals 52 Week Low
₹1318.90
Operating Margin
42.00%
Profit Margin
30.18%
ACUTAAS Revenue (TTM)
₹444.00
EBITDA
₹195.00
Net Income
₹134.00
Total Assets
₹1,984.00
Total Equity
₹1,711.00
Acutaas Chemicals Current Share Price Chart
Track the current Acutaas Chemicals share price and stock price with an interactive chart. Analyse ACUTAAS price trends, trading volume, historical performance, and volatility across different timeframes — the complete Acutaas Chemicals stock quote in one place.
Acutaas Chemicals Company Profile - Fundamental Screener
Screen Acutaas Chemicals company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for ACUTAAS shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE00FF01025
Acutaas Chemicals Balance Sheet Screener
Screen ACUTAAS balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Total Assets | 1,984 | 1,549 | 1,096 | 767 | 659 | 413 | 232 | 213 |
| Current Assets | 881 | 792 | 496 | 457 | 430 | 216 | 121 | 124 |
| Fixed Assets | 745 | 570 | 427 | 259 | 205 | 186 | 85 | 79 |
| Liabilities | ||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 42 | 27 | 128 | 10 | 7 | 80 | 26 | 25 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||
| Total Equity | 1,711 | 1,320 | 683 | 594 | 522 | 167 | 112 | 82 |
| Share Capital | 41 | 41 | 37 | 36 | 36 | 32 | 11 | 11 |
| Reserves & Surplus | 1,613 | 1,269 | 637 | 558 | 486 | 135 | 101 | 72 |
Acutaas Chemicals Income Statement Screener - Profit & Revenue Analysis
Screen Acutaas Chemicals income statement and profit fundamentals.
Analyze ACUTAAS quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Acutaas Chemicals share price evaluation.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 444 | 332 | 314 | 223 | 316 | 398 | 226 | 178 | 255 | 277 | 186 | 155 | 174 | 170 | 144 |
| Expenses | 249 | 217 | 224 | 156 | 211 | 243 | 182 | 147 | 198 | 206 | 146 | 120 | 179 | 140 | 118 |
| EBITDA | 195 | 115 | 91 | 67 | 105 | 155 | 44 | 31 | 57 | 70 | 41 | 35 | -5 | 30 | 26 |
| Operating Profit % | 42.00% | 34.00% | 28.00% | 25.00% | 31.00% | 38.00% | 19.00% | 17.00% | 20.00% | 25.00% | 22.00% | 22.00% | -4.00% | 16.00% | 18.00% |
| Depreciation | 10 | 10 | 7 | 8 | 8 | 10 | 5 | 6 | 7 | 6 | 3 | 4 | 4 | 4 | 3 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 4 | 1 | 1 | 1 | 1 | 1 | 3 | 1 |
| Profit Before Tax | 184 | 104 | 83 | 58 | 96 | 145 | 37 | 20 | 50 | 63 | 37 | 31 | -10 | 24 | 22 |
| Tax | 50 | 29 | 20 | 14 | 24 | 38 | 12 | 5 | 13 | 18 | 10 | 9 | 7 | 6 | 1 |
| Net Profit | 134 | 75 | 63 | 44 | 72 | 106 | 26 | 15 | 38 | 46 | 27 | 22 | -17 | 18 | 21 |
| EPS | 16.09 | 9.07 | 7.80 | 5.41 | 8.82 | 13.19 | 6.85 | 3.67 | 9.38 | 11.35 | 7.47 | 4.57 | -4.67 | 4.83 | 6.22 |
Acutaas Chemicals Cash Flow Screener - Liquidity Fundamentals
Screen ACUTAAS cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 292 | 118 | 125 | 66 | -12 | 28 | 27 | 15 | 9 | 29 |
| Investing Activities | -266 | -224 | -365 | -33 | -121 | -101 | -24 | -21 | -25 | -19 |
| Financing Activities | 4 | 261 | 239 | -12 | 140 | 72 | 0 | 6 | 15 | -7 |
| Net Cash Flow | 30 | 156 | -1 | 20 | 8 | -1 | 3 | 0 | -2 | 3 |
Acutaas Chemicals Shareholding Pattern Screener
See Acutaas Chemicals shareholding pattern with promoter, FII, and DII holdings.
Check Acutaas Chemicals promoter holding and ownership changes for ACUTAAS on TickJournal.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-May |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 32.66% | 32.66% | 35.96% | 32.66% | 32.66% | 32.66% | 39.91% | 39.07% |
| FII Holding | 19.48% | 21.61% | 16.48% | 16.94% | 16.85% | 16.67% | 8.97% | 10.01% |
| DII Holding | 19.60% | 19.56% | 18.31% | 22.38% | 22.59% | 21.70% | 6.81% | 8.81% |
| Govt Holding | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.00% | 0.00% |
| Public Holding | 23.21% | 21.72% | 24.19% | 23.27% | 22.79% | 23.53% | 30.01% | 28.79% |
| Other Holding | 5.03% | 4.44% | 5.05% | 4.74% | 5.10% | 5.43% | 14.30% | 13.33% |
| Shareholder Count | 112,939 | 125,569 | 114,060 | 119,890 | 108,664 | 110,363 | 95,784 | 92,721 |
Acutaas Chemicals Share Dividend Screener - Share Yield Analysis
Check Acutaas Chemicals dividend history with payout and yield data.
View Acutaas Chemicals dividend details including ex-dates and amounts for ACUTAAS stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹2.50 | 0.07% |
| 2025-March | ₹1.50 | 0.06% |
| 2024-March | ₹3.00 | 0.25% |
| 2023-March | ₹3.00 | 0.55% |
| 2022-March | ₹3.00 | 0.67% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Acutaas Chemicals Stock Index Membership
See which indices include Acutaas Chemicals stock.
Check ACUTAAS index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE 1000
BSE INDEX BSE HC
BSE INDEX SMLCAP
NIFTY MICROCAP250
NIFTY TOTAL MKT
Acutaas Chemicals Market Events Screener - Corporate Actions
Get Acutaas Chemicals corporate actions including splits, bonuses, and buybacks.
Check Acutaas Chemicals stock events that may affect ACUTAAS share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-24 | 2026-09-24 | Annual General Meeting | NA | 6.57% |
| 2026-09-17 | 2026-09-17 | Dividend | ₹ 2.50 /share | 35.07% |
| 2026-07-24 | 2026-07-24 | Quarterly Result Announcement | NA | -4.40% |
| 2026-04-30 | 2026-04-30 | Quarterly Result Announcement | NA | 4.41% |
| 2026-01-28 | 2026-01-28 | Quarterly Result Announcement | NA | 6.40% |
| 2025-10-17 | 2025-10-17 | Quarterly Result Announcement | NA | 9.21% |
| 2025-09-25 | 2025-09-25 | Annual General Meeting | NA | 2.54% |
| 2025-09-18 | 2025-09-18 | Dividend | ₹ 1.50 /share | 30.23% |
| 2025-07-30 | 2025-07-30 | Quarterly Result Announcement | NA | -1.68% |
| 2025-05-10 | 2025-05-10 | Extraordinary General Meeting | NA | -1.28% |
| 2025-05-02 | 2025-05-02 | Quarterly Result Announcement | NA | 2.71% |
| 2025-04-25 | 2025-04-25 | Split | 5:10 | -1.69% |
| 2025-04-16 | 2025-04-16 | Change Of Name | NA | 0.00% |
| 2025-01-28 | 2025-01-28 | Quarterly Result Announcement | NA | -3.43% |
| 2024-10-29 | 2024-10-29 | Quarterly Result Announcement | NA | 9.18% |
Acutaas Chemicals Competitors Screener - Peer Comparison
Screen ACUTAAS competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 440,278 | 36.48 | 61,674 | 12.69% | 11,565 | 33.19 |
| Divis Laboratories | 244,178 | 84.64 | 11,067 | 13.95% | 2,568 | 59.21 |
| Torrent Pharmaceuticals | 184,478 | 87.77 | 13,886 | 20.34% | 2,138 | 44.26 |
| Zydus Life Science | 110,585 | 24.32 | 27,658 | 17.64% | 5,026 | 41.59 |
| Cipla | 109,140 | 32.86 | 29,045 | 2.24% | 3,870 | 32.08 |
| Laurus Labs | 104,025 | 97.64 | 6,868 | 22.01% | 890 | 60.27 |
| Dr Reddys Laboratories | 95,570 | 30.44 | 35,059 | 3.90% | 4,158 | 41.23 |
| Aurobindo Pharma | 95,513 | 25.98 | 34,145 | 5.56% | 3,503 | 53.00 |
| Lupin | 94,336 | 17.27 | 29,039 | 26.75% | 5,356 | 24.64 |
| Mankind Pharma | 94,184 | 45.49 | 14,636 | 14.85% | 1,938 | 37.66 |
Acutaas Chemicals Company Announcements - News Screener
Screen ACUTAAS latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-09-15 | Intimation Under Regulation 30 Of The SEBI (LODR) Regulations 2015 - Grant Of Patent | - |
| 2026-09-04 | Intimation Under Regulation 30 Of The SEBI (LODR) Regulations 2015 - Inauguration Of New Pilot Plant | - |
| 2026-08-31 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-29 | TDS Communication To Shareholders | - |
| 2026-08-29 | Intimation Of Record Date For The Purpose Of Final Dividend | - |
| 2026-08-29 | Business Responsibility and Sustainability Reporting (BRSR) | - |
| 2026-08-29 | Reg. 34 (1) Annual Report. | - |
| 2026-08-29 | Notice Of The 19Th AGM Scheduled To Be Held On Thursday September 24 2026 | - |
| 2026-08-28 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-08-24 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-22 | Intimation Under Regulation 30 Of The SEBI (LODR) Regulations 2015 | - |
| 2026-08-18 | Intimation Under Regulation 30 Of SEBI LODR Regulations 2015 - Approval Under ECMS Scheme | - |
| 2026-08-08 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-07-28 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2026-07-25 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-07-24 | Earnings Call Recording Pursuant To SEBI (LODR) Regulations 2015 | - |
| 2026-07-24 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-07-24 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-07-24 | Unaudited Standalone And Consolidated Financial Results For First Quarter Ended June 30 2026 | - |
| 2026-07-24 | Board Meeting Outcome for Outcome Of Board Meeting Held On July 24 2026 | - |